Erratum: Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis (Proceedings of the National Academy of Sciences of the United States of America (2010) 107, 6 (2586-2591) DOI: 10.1073/pnas.0913054107);Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 6, 2010, Pages 2586-2591

  Schuerwegh, A J M ^a   Ioan Facsinay, A ^a   Dorjee A L ^a   Roos, J ^a   Bajema, I M ^a   Van Der Voort, E I H ^a   Huizinga, T W J ^a   Toes, R E M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Basophil; Citrullination; Histamine; Mast cell; Synovium

Indexed keywords

ANTICITRULLINATED PROTEIN ANTIBODY; ANTIGEN; AUTOANTIBODY; CITRULLINATED ANTIGEN; FIBRINOGEN; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ARTICLE; BASOPHIL; CONTROLLED STUDY; ELUTION; FEMALE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; JOINT BIOPSY; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MAST CELL DEGRANULATION; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIUM;

RATTUS;

EID: 77249097859     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1320459110     Document Type: Erratum

References (35)

1. Schellekens GA, et al. (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155-163.
2. van Gaalen FA, et al. (2004) Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort study. Arthritis Rheum 50:709-715.
3. Meyer O, et al. (2003) Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 62: 120-126.
4. van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW (2005) Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 7:R949-R958.
5. Kuhn KA, et al. (2006) Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 116:961-973.
6. Uysal H, et al. (2009) Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. J Exp Med 206:449-462.
7. Clavel C, et al. (2008) Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen. Arthritis Rheum 58:678-688.
8. Ioan-Facsinay A, et al. (2002) Fcgamma RI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 16:391-402.
9. Vogel L, Lüttkopf D, Hatahet L, Haustein D, Vieths S (2005) Development of a functional in vitro assay as a novel tool for the standardization of allergen extracts in the human system. Allergy 60:1021-1028.
10. MacGlashan D, Jr, et al. (1998) In vitro regulation of FcepsilonRIalpha expression on human basophils by IgE antibody. Blood 91:1633-1643.
11. Yamaguchi M, et al. (1999) IgE enhances Fc epsilon receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: Synergistic effect of IL-4 and IgE on human mast cell Fc epsilon receptor I expression and mediator release. J Immunol 162:5455-5465.
12. Rivera J, Gilfillan AM (2006) Molecular regulation of mast cell activation. J Allergy Clin Immunol, 117:1214-1225, quiz 1226.
13. Galli SJ, Tsai M, Piliponsky AM (2008) The development of allergic inflammation. Nature 454:445-454.
14. Fairley JA, et al. (2007) A pathogenic role for IgE in autoimmunity: Bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu/nu mice. J Invest Dermatol 127:2605-2611.
15. Dimson OG, et al. (2003) Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid. J Invest Dermatol 120:784-788.
16. Malone DG, Irani AM, Schwartz LB, Barrett KE, Metcalfe DD (1986) Mast cell numbers and histamine levels in synovial fluids from patients with diverse arthritides. Arthritis Rheum 29:956-963.
17. Crisp AJ, Chapman CM, Kirkham SE, Schiller AL, Krane SM (1984) Articular mastocytosis in rheumatoid arthritis. Arthritis Rheum 27:845-851.
18. Lee DM, et al. (2002) Mast cells: A cellular link between autoantibodies and inflammatory arthritis. Science 297:1689-1692.
19. Nigrovic PA, et al. (2007) Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1. Proc Natl Acad Sci USA 104:2325-2330.
20. Malone DG, Metcalfe DD (1988) Demonstration and characterization of a transient arthritis in rats following sensitization of synovial mast cells with antigen-specific IgE and parenteral challenge with specific antigen. Arthritis Rheum 31:1063-1067.
21. Marcelletti JF, Ohara J, Katz DH (1991) Collagen-induced arthritis in mice. Relationship of collagen-specific and total IgE synthesis to disease. J Immunol 147:4185-4191.
22. De Clerck LS, et al. (1989) Humoral immunity and composition of immune complexes in patients with rheumatoid arthritis, with special reference to IgE-containing immune complexes. Clin Exp Rheumatol 7:485-492.
23. Meretey K, Falus A, Erhardt CC, Maini RN (1982) IgE and IgE-rheumatoid factors in circulating immune complexes in rheumatoid arthritis. Ann Rheum Dis 41:405-408.
24. Bartholomew JS, Evanson JM, Woolley DE (1991) Serum IgE anti-cartilage collagen antibodies in rheumatoid patients. Rheumatol Int 11:37-40.
25. Huizinga TW, et al. (2005) Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 52:3433-3438.
26. Verpoort KN, et al. (2005) Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis. Arthritis Rheum 52:3058-3062.
27. Ding B, et al. (2009) Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region. Arthritis Rheum 60:30-38.
28. van Oosterhout M, et al. (2008) Differences in synovial tissue infiltrates between anticyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis. Arthritis Rheum 58:53-60.
29. van der Pouw Kraan TC, et al. (2003) Rheumatoid arthritis is a heterogeneous disease: Evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum 48:2132-2145.
30. van Aken J, van Bilsen JH, Allaart CF, Huizinga TW, Breedveld FC (2003) The Leiden Early Arthritis Clinic. Clin Exp Rheumatol 21 (5, Suppl 31):S100-S105.
31. Arnett FC, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324.
32. Altman R, et al. (1986) Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 29:1039-1049.
33. Youssef PP, et al. (1998) Quantitative microscopic analysis of inflammation in rheumatoid arthritis synovial membrane samples selected at arthroscopy compared with samples obtained blindly by needle biopsy. Arthritis Rheum 41:663-669.
34. Ioan-Facsinay A, et al. (2008) Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease. Arthritis Rheum 58: 3000-3008.
35. Ebo DG, et al. (2006) Flow-assisted allergy diagnosis: Current applications and future perspectives. Allergy 61:1028-1039.